OK
Therapeutic Areas
HVR Cardio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CathHELIX Transcatheter Mitral Repair System | Mitral Valve Regurgitation (likely degenerative) | Pre-clinical / Early Clinical |
Leadership Team at HVR Cardio
KS
Kris Siverhus
Director, Research and Development
CL
Chris Larson
Director Project Management
JV
Jani Virtanen
Head of Regulatory Affairs and Quality
TF
Tom Fleming
Sr. Consultant
PS
Pekka Simula
Chairman of the Board
MW
Matthias Weber
Board Member
HT
Hardip Thakerar
Board Member